Predicting and preventing the future: actively managing multiple sclerosis.
AffiliationDepartment of Neurology, St Vincent's University Hospital, Elm Park, Dublin 4,, Ireland. firstname.lastname@example.org
MeSHAge of Onset
Immunologic Factors/therapeutic use
Inflammation/physiopathology/prevention & control
Multiple Sclerosis/drug therapy/physiopathology/*prevention & control/*therapy
Multiple Sclerosis, Relapsing-Remitting/prevention & control/therapy
MetadataShow full item record
CitationPract Neurol. 2009 Jun;9(3):133-43, discussion 144.
AbstractRelapsing-remitting multiple sclerosis (MS) has a highly variable clinical course but a number of demographic, clinical and MRI features can guide the clinician in the assessment of disease activity and likely disability outcome. It is also clear that the inflammatory activity in the first five years of relapsing-remitting MS results in the neurodegenerative changes seen in secondary progressive MS 10-15 years later. While conventional first-line disease modifying therapy has an effect on relapses, about one third of patients have a suboptimal response to treatment. With the advent of highly active second-line therapies with their evident marked suppression of inflammation, the clinician now has the tools to manage the course of relapsing-remitting MS more effectively. The development of treatment optimisation recommendations based on the clinical response to first-line therapies can guide the neurologist in more active management of the early course of relapsing-remitting MS, with the aim of preventing both acute inflammatory axonal injury and the neurodegenerative process which leads to secondary progressive MS.
- Natural history of multiple sclerosis: a unifying concept.
- Authors: Confavreux C, Vukusic S
- Issue date: 2006 Mar
- [Immunomodulatory therapy in multiple sclerosis].
- Authors: Csépány T, Bereczki D
- Issue date: 2004 Nov 20
- Treatment of multiple sclerosis.
- Authors: Anlar O
- Issue date: 2009 Jun
- Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
- Authors: Bates D
- Issue date: 2011 Jan 4
- Clinically isolated syndromes: predicting and delaying multiple sclerosis.
- Authors: Thrower BW
- Issue date: 2007 Jun 12